Matches in Wikidata for { <http://www.wikidata.org/entity/Q64836785> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q64836785 description "clinical trial" @default.
- Q64836785 description "ensayu clínicu" @default.
- Q64836785 description "klinisch onderzoek" @default.
- Q64836785 description "клінічне випробування" @default.
- Q64836785 name "Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer" @default.
- Q64836785 name "Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer" @default.
- Q64836785 type Item @default.
- Q64836785 label "Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer" @default.
- Q64836785 label "Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer" @default.
- Q64836785 prefLabel "Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer" @default.
- Q64836785 prefLabel "Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer" @default.
- Q64836785 P1050 Q64836785-3C1D8A51-0EFF-4352-A84D-0AC31B503D2F @default.
- Q64836785 P1132 Q64836785-D241A69A-B364-43A0-BBA2-825D1EBCC65C @default.
- Q64836785 P1476 Q64836785-865BD7F3-21F3-401D-80CA-1A14B94C3BA7 @default.
- Q64836785 P17 Q64836785-76CD834E-2E6D-4407-BF8B-BFD6EFEA06C7 @default.
- Q64836785 P2899 Q64836785-55FDC5BA-C710-4958-9307-F87DCD667A7F @default.
- Q64836785 P3098 Q64836785-C063C1DB-E7A1-49BE-BAC0-76E52F77D98C @default.
- Q64836785 P31 Q64836785-6A6A444C-2633-4C37-A8F4-51775E327F68 @default.
- Q64836785 P4844 Q64836785-537F3389-7B9D-4141-98E1-468A0C08D441 @default.
- Q64836785 P580 Q64836785-0586EEA7-8A50-48CA-8E55-C21E41CB5FC9 @default.
- Q64836785 P582 Q64836785-CE9B2E49-F5D5-4B86-B65E-93E478E02F7A @default.
- Q64836785 P6099 Q64836785-C352DB34-6E45-473C-8A2D-37E96613BC5C @default.
- Q64836785 P6153 Q64836785-35AC9984-12D7-4B04-BD8A-03BB99A15256 @default.
- Q64836785 P8363 Q64836785-966886F1-5AAE-44AF-8422-BE0802DAEA99 @default.
- Q64836785 P859 Q64836785-683C9FB8-BC76-4E69-A78E-B3A31D708517 @default.
- Q64836785 P1050 Q33525 @default.
- Q64836785 P1132 "+27" @default.
- Q64836785 P1476 "A Phase I Trial of Interleukin-2 (Aldesleukin) and Pembrolizumab Combination Therapy for Patients With Advanced Renal Cell Carcinoma" @default.
- Q64836785 P17 Q30 @default.
- Q64836785 P2899 "+18" @default.
- Q64836785 P3098 "NCT03260504" @default.
- Q64836785 P31 Q30612 @default.
- Q64836785 P4844 Q13896859 @default.
- Q64836785 P580 "2018-08-28T00:00:00Z" @default.
- Q64836785 P582 "2021-03-17T00:00:00Z" @default.
- Q64836785 P6099 Q5452194 @default.
- Q64836785 P6153 Q219563 @default.
- Q64836785 P8363 Q78089383 @default.
- Q64836785 P859 Q219563 @default.